- Home
- FGL vs AKTX Comparison
FGL vs AKTX Comparison
Compare FGL & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGL
- AKTX
- Stock Information
- Founded
- FGL 2021
- AKTX N/A
- Country
- FGL Malaysia
- AKTX United States
- Employees
- FGL N/A
- AKTX N/A
- Industry
- FGL
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- FGL
- AKTX Health Care
- Exchange
- FGL NYSE
- AKTX Nasdaq
- Market Cap
- FGL 25.4M
- AKTX 29.1M
- IPO Year
- FGL 2024
- AKTX N/A
- Fundamental
- Price
- FGL $1.28
- AKTX $1.35
- Analyst Decision
- FGL
- AKTX
- Analyst Count
- FGL 0
- AKTX 0
- Target Price
- FGL N/A
- AKTX N/A
- AVG Volume (30 Days)
- FGL 34.2K
- AKTX 32.7K
- Earning Date
- FGL 06-21-2025
- AKTX 05-19-2025
- Dividend Yield
- FGL N/A
- AKTX N/A
- EPS Growth
- FGL N/A
- AKTX N/A
- EPS
- FGL N/A
- AKTX N/A
- Revenue
- FGL $20,205,441.00
- AKTX N/A
- Revenue This Year
- FGL N/A
- AKTX N/A
- Revenue Next Year
- FGL N/A
- AKTX N/A
- P/E Ratio
- FGL N/A
- AKTX N/A
- Revenue Growth
- FGL N/A
- AKTX N/A
- 52 Week Low
- FGL $1.16
- AKTX $0.85
- 52 Week High
- FGL $5.26
- AKTX $4.40
- Technical
- Relative Strength Index (RSI)
- FGL N/A
- AKTX 52.00
- Support Level
- FGL N/A
- AKTX $1.18
- Resistance Level
- FGL N/A
- AKTX $1.42
- Average True Range (ATR)
- FGL 0.00
- AKTX 0.10
- MACD
- FGL 0.00
- AKTX -0.01
- Stochastic Oscillator
- FGL 0.00
- AKTX 56.67
About FGL FOUNDER GROUP LTD
Founder Group Ltd is a solar solutions provider in Malaysia, offering end-to-end services for commercial and industrial sectors, as well as large-scale solar power projects, encompassing project design, engineering, and comprehensive project management. Its focus is on two key segments: large-scale solar projects and commercial and industrial (C&I) solar projects. Large-scale solar projects are utility scale solar PV power plants with installed generating capacity of 1 MWac or more. C&I projects are smaller scale solar projects where the solar PV systems are installed on rooftops and are designed to generate electricity for commercial and industrial properties for their own consumption, such as factories, warehouses and commercial stores. Its revenue is derived from Malaysia.
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).